A. Le Liboux

734 total citations
18 papers, 613 citations indexed

About

A. Le Liboux is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, A. Le Liboux has authored 18 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in A. Le Liboux's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Inflammatory mediators and NSAID effects (3 papers). A. Le Liboux is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Inflammatory mediators and NSAID effects (3 papers). A. Le Liboux collaborates with scholars based in France, United States and Austria. A. Le Liboux's co-authors include Guy Montay, Armand Frydman, J. Gaillot, L. D. Jacobs, Björn Engström, Bruno Boutouyrie, Marie‐Laure Ozoux, Umesh Shukla, Ger‐Jan Sanderink and Christer Rolf and has published in prestigious journals such as The American Journal of Cardiology, Journal Of Clinical Periodontology and Clinical Pharmacology & Therapeutics.

In The Last Decade

A. Le Liboux

18 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Le Liboux France 12 156 148 115 90 73 18 613
E. Mueller Switzerland 17 120 0.8× 192 1.3× 100 0.9× 193 2.1× 71 1.0× 40 881
Y. Le Roux France 10 143 0.9× 127 0.9× 125 1.1× 92 1.0× 60 0.8× 15 453
Thomas J. Comstock United States 13 104 0.7× 93 0.6× 48 0.4× 64 0.7× 52 0.7× 20 539
Dolly A. Parasrampuria United States 15 80 0.5× 333 2.3× 223 1.9× 57 0.6× 111 1.5× 31 922
S. D. Deodhar India 14 183 1.2× 43 0.3× 15 0.1× 140 1.6× 163 2.2× 59 1.0k
Michael A. Goulder United Kingdom 16 261 1.7× 150 1.0× 44 0.4× 144 1.6× 93 1.3× 17 828
José Pedro L. Nunes Portugal 17 55 0.4× 362 2.4× 20 0.2× 112 1.2× 146 2.0× 95 1.0k
M. Raghoebar Netherlands 11 113 0.7× 150 1.0× 116 1.0× 23 0.3× 46 0.6× 31 476
Terri Levien United States 13 56 0.4× 43 0.3× 10 0.1× 86 1.0× 117 1.6× 134 626
Dennis J. Cada United States 11 50 0.3× 43 0.3× 12 0.1× 56 0.6× 86 1.2× 181 568

Countries citing papers authored by A. Le Liboux

Since Specialization
Citations

This map shows the geographic impact of A. Le Liboux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Le Liboux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Le Liboux more than expected).

Fields of papers citing papers by A. Le Liboux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Le Liboux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Le Liboux. The network helps show where A. Le Liboux may publish in the future.

Co-authorship network of co-authors of A. Le Liboux

This figure shows the co-authorship network connecting the top 25 collaborators of A. Le Liboux. A scholar is included among the top collaborators of A. Le Liboux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Le Liboux. A. Le Liboux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sanderink, Ger‐Jan, A. Le Liboux, Marie‐Laure Ozoux, et al.. (2002). The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers. Clinical Pharmacology & Therapeutics. 72(3). 308–318. 144 indexed citations
2.
Kokki, Merja, A. Le Liboux, Antti Jekunen, Guy Montay, & M. Heikkinen. (2000). Pharmacokinetics of Ketoprofen Syrup in Small Children. The Journal of Clinical Pharmacology. 40(4). 354–359. 13 indexed citations
3.
4.
Liboux, A. Le, Stéphane Kirkesseli, Guy Montay, et al.. (1999). A Comparison of the Pharmacokinetics and Tolerability of Riluzole after Repeat Dose Administration in Healthy Elderly and Young Volunteers. The Journal of Clinical Pharmacology. 39(5). 480–486. 43 indexed citations
5.
Liboux, A. Le, Olivier Pasquier, & Guy Montay. (1998). Simultaneous high-performance liquid chromatographic determination of quinupristin, dalfopristin and their main metabolites in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 708(1-2). 161–168. 13 indexed citations
6.
Liboux, A. Le, et al.. (1997). Single‐ and Multiple‐Dose Pharmacokinetics of Riluzole in White Subjects. The Journal of Clinical Pharmacology. 37(9). 820–827. 68 indexed citations
7.
Rolf, Christer, et al.. (1997). An open, randomized study of ketoprofen in patients in surgery for Achilles or patellar tendinopathy.. PubMed. 24(8). 1595–8. 25 indexed citations
8.
Liboux, A. Le, et al.. (1994). Kinetics of spiramycin/metronidazole (Rodogyl®) in human gingival crevicular fluid, saliva and blood. Journal Of Clinical Periodontology. 21(9). 595–600. 24 indexed citations
9.
Liboux, A. Le, et al.. (1994). Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen. European Journal of Clinical Pharmacology. 47(4). 361–366. 10 indexed citations
10.
Montay, Guy, et al.. (1992). A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500. Journal of Antimicrobial Chemotherapy. 30(suppl A). 123–131. 50 indexed citations
11.
Humbert, Guy, Guy Montay, A. Le Liboux, et al.. (1991). Influence of rifampin on the pharmacokinetics of pefloxacin. Clinical Pharmacology & Therapeutics. 50(6). 682–687. 11 indexed citations
12.
Montay, Guy, Y. Le Roux, A. Le Liboux, et al.. (1991). Comparative Bioavailability Study of Cefixime Administered as Tablets or Aqueous Solution. Drugs. 42(Supplement 4). 6–9. 11 indexed citations
13.
Fleurot, O., Brigitte Lecocq, A. Le Liboux, et al.. (1991). A comparative pharmacokinetic and pharmacodynamic study of conventional and sustained‐release preparations of acebutolol in healthy volunteers. Fundamental and Clinical Pharmacology. 5(7). 601–609. 1 indexed citations
14.
Viron, B, Martine De Meyer, A. Le Liboux, et al.. (1990). Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure.. PubMed. 5 Suppl 2. 95–104. 6 indexed citations
15.
Montay, Guy, et al.. (1989). [Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg].. PubMed. 18(32). 1583–6. 6 indexed citations
16.
Frydman, Armand, H. W. Diekmann, René Bruno, et al.. (1989). Pharmacokinetics of nicorandil. The American Journal of Cardiology. 63(21). J25–J33. 71 indexed citations
17.
Liboux, A. Le, Armand Frydman, & J. Gaillot. (1987). Simultaneous determination of zopiclone and its two major metabolites (n-oxide and n-desmethyl) in human biological fluids by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 417. 151–158. 37 indexed citations
18.
Roux, Étienne, et al.. (1983). Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination. European Journal of Clinical Pharmacology. 24(6). 801–806. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Mueller Breakdown of academic impact, for papers by Y. Le Roux Breakdown of academic impact, for papers by Thomas J. Comstock Breakdown of academic impact, for papers by Dolly A. Parasrampuria Breakdown of academic impact, for papers by S. D. Deodhar Breakdown of academic impact, for papers by Michael A. Goulder Breakdown of academic impact, for papers by José Pedro L. Nunes Breakdown of academic impact, for papers by M. Raghoebar Breakdown of academic impact, for papers by Terri Levien Breakdown of academic impact, for papers by Dennis J. Cada
Rankless by CCL
2026